(Q45356884)
English
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mG
scientific article published on 15 December 2010
Statements
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (English)
Filippo Caraci
Gemma Molinaro
Barbara Riozzi
Xushan Wang
Beverly A Heinz
Eric S Nisenbaum
Thomas C Britton
Agata Copani
15 December 2010
1 reference